Literature DB >> 29708180

Stereotactic body radiation therapy vs. surgery in early-stage non-small cell lung cancer: lessons learned, current recommendations, future directions.

Sibo Tian1, Kristin A Higgins1, Walter J Curran1, Richard J Cassidy1.   

Abstract

Entities:  

Year:  2018        PMID： 29708180      PMCID： PMC5906375          DOI： 10.21037/jtd.2018.01.161

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  16 in total

1.  Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.

Authors:  Sashendra Senthi; Frank J Lagerwaard; Cornelis J A Haasbeek; Ben J Slotman; Suresh Senan
Journal:  Lancet Oncol       Date:  2012-06-22       Impact factor: 41.316

2.  Dosimetric impact of online correction via cone-beam CT-based image guidance for stereotactic lung radiotherapy.

Authors:  Ana Paula Galerani; Inga Grills; Geoffrey Hugo; Larry Kestin; Nasiruddin Mohammed; K Kenneth Chao; Andrew Suen; Alvaro Martinez; Di Yan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-18       Impact factor: 7.038

3.  Stereotactic body radiotherapy using a radiobiology-based regimen for stage I non-small-cell lung cancer: five-year mature results.

Authors:  Yuta Shibamoto; Chisa Hashizume; Fumiya Baba; Shiho Ayakawa; Akifumi Miyakawa; Taro Murai; Taiki Takaoka; Yukiko Hattori; Ryuji Asai
Journal:  J Thorac Oncol       Date:  2015-06       Impact factor: 15.609

4.  Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.

Authors:  Gregory M M Videtic; Jessica Donington; Meredith Giuliani; John Heinzerling; Tomer Z Karas; Chris R Kelsey; Brian E Lally; Karen Latzka; Simon S Lo; Drew Moghanaki; Benjamin Movsas; Andreas Rimner; Michael Roach; George Rodrigues; Shervin M Shirvani; Charles B Simone; Robert Timmerman; Megan E Daly
Journal:  Pract Radiat Oncol       Date:  2017-06-05

5.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

6.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

7.  Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques.

Authors:  Andrea Holt; Corine van Vliet-Vroegindeweij; Anton Mans; José S Belderbos; Eugène M F Damen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-06       Impact factor: 7.038

8.  Stage I Lung SBRT Clinical Practice Patterns.

Authors:  Christopher D Corso; Henry S Park; Amy C Moreno; Anthony W Kim; James B Yu; Zain A Husain; Roy H Decker
Journal:  Am J Clin Oncol       Date:  2017-08       Impact factor: 2.339

9.  Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.

Authors:  Shervin M Shirvani; Jing Jiang; Joe Y Chang; James Welsh; Anna Likhacheva; Thomas A Buchholz; Stephen G Swisher; Benjamin D Smith
Journal:  JAMA Surg       Date:  2014-12       Impact factor: 14.766

10.  The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection.

Authors:  M P Snee; L McParland; F Collinson; C M Lowe; A Striha; D R Baldwin; B Naidu; D Sebag-Montefiore; W M Gregory; J Bestall; J Hewison; S Hinsley; K Franks
Journal:  Pilot Feasibility Stud       Date:  2016-02-01
View more
  6 in total

1.  Definitive single fraction stereotactic ablative radiotherapy for inoperable early-stage breast cancer: A case report.

Authors:  Manasa Veluvolu; Mausam Patel; Ganesh Narayanasamy; Thomas Kim
Journal:  Rep Pract Oncol Radiother       Date:  2020-07-11

Review 2.  Microwave Ablation in Primary Lung Malignancies.

Authors:  Amgad M Moussa; Etay Ziv; Stephen B Solomon; Juan C Camacho
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

3.  Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs.

Authors:  Yusef A Syed; William Stokes; Manali Rupji; Yuan Liu; Onkar Khullar; Nikhil Sebastian; Kristin Higgins; Jeffrey D Bradley; Walter J Curran; Suresh Ramalingam; James Taylor; Manu Sancheti; Felix Fernandez; Drew Moghanaki
Journal:  Chest       Date:  2021-11-14       Impact factor: 9.410

4.  Verification of an optimizer algorithm by the beam delivery evaluation of intensity-modulated arc therapy plans.

Authors:  Tamas Pocza; Domonkos Szegedi; Tibor Major; Csilla Pesznyak
Journal:  Radiol Oncol       Date:  2021-11-19       Impact factor: 2.991

Review 5.  Which patients benefit most from stereotactic body radiotherapy or surgery in medically operable non-small cell lung cancer? An in-depth look at patient characteristics on both sides of the debate.

Authors:  Gail Wan Ying Chua; Kevin Lee Min Chua
Journal:  Thorac Cancer       Date:  2019-08-06       Impact factor: 3.500

6.  Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer.

Authors:  Nicholas R Mayne; Belle K Lin; Alice J Darling; Vignesh Raman; Deven C Patel; Douglas Z Liou; Thomas A D'Amico; Chi-Fu Jeffrey Yang
Journal:  Ann Surg       Date:  2020-12       Impact factor: 13.787
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.